The asset manager’s biotech portfolio managers see a strong setup for biotech stocks in the coming quarters.

The asset manager’s biotech portfolio managers see a strong setup for biotech stocks in the coming quarters.
The asset manager aims to grow its footprint in the private credit market.
Indices’ moment in the sun, Janus Henderson’s sanguine about markets, GAM and SharkNinja, Berkshire Hathaway’s monster cash pile, Private markets are stirring, Fund failure shocker, Happy birthday Singapore and much more.
While global debt levels appear sustainable for the time being, they remain vulnerable to poor political management.
BlackRock loves manufacturing, Small cap renaissance, Entropy in markets, Silver bugs and their fanaticism, China’s windy electricity, Life in cartoon, Ancient wisdom, Advertising and much more.
FSA highlights the funds with the highest returns in the first half of 2024.
Small-cap weakness has persisted in spite of a revival in economic conditions – until recently.
San Lo John’s hire rounds out Janus Henderson’s efforts to grow its intermediary sales team in the region.
This week FSA presents a quick presentation of two Japan small/mid cap funds: the BlackRock Japan Small and Mid-Cap Opportunities fund and the Janus Henderson Horizon Japanese Smaller Companies fund.
FSA looks at the five top-performing technology funds eligible for distribution in Hong Kong and Singapore.
Part of the Mark Allen Group.